Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
417M
-
Number of holders
-
157
-
Total 13F shares, excl. options
-
122M
-
Shares change
-
+23.6M
-
Total reported value, excl. options
-
$262M
-
Value change
-
+$44.4M
-
Put/Call ratio
-
0.57
-
Number of buys
-
85
-
Number of sells
-
-60
-
Price
-
$2.14
Significant Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) as of Q2 2022
200 filings reported holding CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock as of Q2 2022.
CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) has 157 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 122M shares
of 417M outstanding shares and own 29.39% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (32.1M shares), BlackRock Inc. (24.4M shares), STATE STREET CORP (7.95M shares), PNC Financial Services Group, Inc. (6.21M shares), GEODE CAPITAL MANAGEMENT, LLC (6.02M shares), NORTHERN TRUST CORP (3.6M shares), TWO SIGMA ADVISERS, LP (2.88M shares), JUPITER ASSET MANAGEMENT LTD (2.66M shares), BAILLIE GIFFORD & CO (2.65M shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (2.48M shares).
This table shows the top 157 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.